Home
/
Sonoma Pharmaceuticals, Inc.
/
Financials
/
Quarterly
Sonoma Pharmaceuticals, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Sonoma Pharmaceuticals, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Dec 31, 2025
$4.35M
Feb 10, 2026
Q2
2026
Sep 30, 2025
$5.60M
Nov 4, 2025
Q1
2026
Jun 30, 2025
$4.02M
Aug 7, 2025
Q3
2026
Dec 31, 2024
$3.56M
Feb 10, 2026
Q2
2026
Sep 30, 2024
$3.58M
Nov 4, 2025
Q1
2026
Jun 30, 2024
$3.39M
Aug 7, 2025
Q3
2025
Dec 31, 2023
$3.14M
Feb 5, 2025
Q2
2025
Sep 30, 2023
$2.73M
Nov 7, 2024
Q1
2025
Jun 30, 2023
$3.43M
Aug 8, 2024
Q3
2024
Dec 31, 2022
$2.94M
Feb 8, 2024
Q2
2024
Sep 30, 2022
$3.33M
Nov 13, 2023
Q1
2024
Jun 30, 2022
$3.98M
Aug 10, 2023
Q3
2023
Dec 31, 2021
$2.90M
Feb 14, 2023
Q2
2023
Sep 30, 2021
$3.74M
Nov 14, 2022
Q1
2023
Jun 30, 2021
$3.68M
Aug 11, 2022
Q3
2020
Dec 31, 2019
$4.68M
Feb 14, 2020
Q2
2020
Sep 30, 2019
$4.97M
Nov 14, 2019
Q1
2020
Jun 30, 2019
$4.71M
Aug 13, 2019
Q3
2020
Dec 31, 2018
$5.28M
Feb 14, 2020
Q2
2020
Sep 30, 2018
$4.94M
Nov 14, 2019
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Dec 31, 2025
$4.35M
Feb 10, 2026
Q2
2026
Sep 30, 2025
$5.60M
Nov 4, 2025
Q1
2026
Jun 30, 2025
$4.02M
Aug 7, 2025
Q3
2026
Dec 31, 2024
$3.56M
Feb 10, 2026
Q2
2026
Sep 30, 2024
$3.58M
Nov 4, 2025
Q1
2026
Jun 30, 2024
$3.39M
Aug 7, 2025
Q3
2025
Dec 31, 2023
$3.14M
Feb 5, 2025
Q2
2025
Sep 30, 2023
$2.73M
Nov 7, 2024
Q1
2025
Jun 30, 2023
$3.43M
Aug 8, 2024
Q3
2024
Dec 31, 2022
$2.94M
Feb 8, 2024
Q2
2024
Sep 30, 2022
$3.33M
Nov 13, 2023
Q1
2024
Jun 30, 2022
$3.98M
Aug 10, 2023
Q3
2023
Dec 31, 2021
$2.90M
Feb 14, 2023
Q2
2023
Sep 30, 2021
$3.74M
Nov 14, 2022
Q1
2023
Jun 30, 2021
$3.68M
Aug 11, 2022
Q3
2022
Dec 31, 2020
$4.94M
Feb 11, 2022
Q2
2022
Sep 30, 2020
$5.77M
Nov 15, 2021
Q1
2022
Jun 30, 2020
$5.77M
Aug 16, 2021
Q3
2021
Dec 31, 2019
$4.40M
Feb 16, 2021
Q2
2021
Sep 30, 2019
$4.73M
Nov 20, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2011
Sep 30, 2011
$3.66M
Nov 3, 2011
Q1
2011
Jun 30, 2011
$2.94M
Aug 9, 2011
Q2
2011
Sep 30, 2010
$2.47M
Nov 3, 2011
Q1
2011
Jun 30, 2010
$2.26M
Aug 9, 2011
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Dec 31, 2025
($819.0K)
Feb 10, 2026
Q2
2026
Sep 30, 2025
($534.0K)
Nov 4, 2025
Q3
2026
Sep 30, 2025
($534.0K)
Feb 10, 2026
Q1
2026
Jun 30, 2025
($1.24M)
Aug 7, 2025
Q3
2026
Jun 30, 2025
($1.24M)
Feb 10, 2026
Q2
2026
Jun 30, 2025
($1.24M)
Nov 4, 2025
Q3
2026
Dec 31, 2024
($928.0K)
Feb 10, 2026
Q3
2026
Sep 30, 2024
($610.0K)
Feb 10, 2026
Q2
2026
Sep 30, 2024
($610.0K)
Nov 4, 2025
Q1
2026
Jun 30, 2024
($1.14M)
Aug 7, 2025
Q3
2026
Jun 30, 2024
($1.14M)
Feb 10, 2026
Q2
2026
Jun 30, 2024
($1.14M)
Nov 4, 2025
Q3
2025
Dec 31, 2023
($866.0K)
Feb 5, 2025
Q3
2025
Sep 30, 2023
($1.48M)
Feb 5, 2025
Q2
2025
Sep 30, 2023
($1.48M)
Nov 7, 2024
Q3
2025
Jun 30, 2023
($1.42M)
Feb 5, 2025
Q2
2025
Jun 30, 2023
($1.42M)
Nov 7, 2024
Q1
2025
Jun 30, 2023
($1.42M)
Aug 8, 2024
Q3
2024
Dec 31, 2022
($1.94M)
Feb 8, 2024
Q2
2024
Sep 30, 2022
($1.02M)
Nov 13, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Dec 31, 2025
($678.0K)
Feb 10, 2026
Q2
2026
Sep 30, 2025
($337.0K)
Nov 4, 2025
Q1
2026
Jun 30, 2025
($1.10M)
Aug 7, 2025
Q3
2026
Dec 31, 2024
($1.03M)
Feb 10, 2026
Q2
2026
Sep 30, 2024
($850.0K)
Nov 4, 2025
Q1
2026
Jun 30, 2024
($1.17M)
Aug 7, 2025
Q3
2025
Dec 31, 2023
($844.0K)
Feb 5, 2025
Q2
2025
Sep 30, 2023
($1.21M)
Nov 7, 2024
Q1
2025
Jun 30, 2023
($1.24M)
Aug 8, 2024
Q3
2024
Dec 31, 2022
($1.83M)
Feb 8, 2024
Q2
2024
Sep 30, 2022
($731.0K)
Nov 13, 2023
Q1
2024
Jun 30, 2022
($855.0K)
Aug 10, 2023
Q3
2023
Dec 31, 2021
($958.0K)
Feb 14, 2023
Q2
2023
Sep 30, 2021
($964.0K)
Nov 14, 2022
Q1
2023
Jun 30, 2021
($904.0K)
Aug 11, 2022
Q3
2022
Dec 31, 2020
($138.0K)
Feb 11, 2022
Q2
2022
Sep 30, 2020
$169.0K
Nov 15, 2021
Q1
2022
Jun 30, 2020
($665.0K)
Aug 16, 2021
Q3
2021
Dec 31, 2019
($1.11M)
Feb 16, 2021
Q2
2021
Sep 30, 2019
($1.29M)
Nov 20, 2020